HEIDI O'BRIEN: Open Payments
NPI 1417057944 · MILFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 13 payments from 10 companies in 2025. Trend: 2023 $470 · 2024 $386 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| TOLMAR, INC. | 3 | $80 |
| Antares Pharma, Inc. | 2 | $51 |
| Davol Inc. | 1 | $44 |
| 180 Medical, Inc. | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| IMMUNITYBIO, INC. | 1 | $25 |
| ABBVIE INC. | 1 | $25 |
| Calyxo, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Teleflex LLC | 1 | $17 |
Products named: XYOSTED, ELIGARD, Magic3 Go Intermittent Urinary Catheter, JATENZO, GENTLECATH, ADSTILADRIN, ANKTIVA, BOTOX.
Industry payments across MA — which companies pay providers there.
